International Business Machines Corp. introduced new IBM z17 and IBM LinuxONE 5 configurations on Tuesday, adding rack-mount and single-frame options across its entire Z and LinuxONE portfolio for the first time. The new systems are designed to help enterprises optimize data center space, improve deployment flexibility, and support AI workloads. IBM shares rose 1.46% to $303.91 in Tuesday's premarket session, contrasting with a decline in broader market indices.

New System Specifications

The new configurations support up to 82 cores and 18 TB of memory. According to IBM, the z17 ME2 delivers up to 10% greater throughput per core than the IBM z16 A02, depending on workload and configuration. The company also unveiled new software, including Infrastructure Management for IBM Z and LinuxONE, IBM COBOL Elevate for z/OS, and Crypto Discovery & Inventory capabilities to simplify infrastructure management, modernization, and post-quantum security.

Tom McPherson, general manager of IBM Z and LinuxONE, stated that the rising number of mission-critical workloads drove the development of these systems. The new IBM z17 systems, IBM LinuxONE Rockhopper 5, and IBM LinuxONE 5 Express are scheduled to become generally available on Aug. 12. IBM Infrastructure Management for IBM Z and LinuxONE will be available on Aug. 14, followed by IBM COBOL Elevate for z/OS on Sept. 18.

Technical Analysis and Market Outlook

IBM remains in a strong long-term uptrend, trading 11.2% above its 20-day simple moving average of $272.90 and 10.6% above its 200-day SMA of $274.49. The stock also sits 18.4% above its 50-day SMA of $256.30 and 20.4% above its 100-day SMA of $252.21. Momentum indicators remain constructive, with the MACD above its signal line and a positive histogram. However, a "death cross" formed in March serves as a longer-term technical caution for some traders. The stock reached a 52-week high of $332.46 in June, which now acts as the next major resistance level, with initial support near $243.50.

Investors are looking ahead to earnings scheduled for July 22. Wall Street expects earnings of $3.02 per share on revenue of $17.86 billion, compared with $2.80 per share and $16.98 billion in the prior-year period. The stock holds a consensus Buy rating with an average price forecast of $300.71. Recent analyst actions include Bank of America Securities raising its price forecast to $330, Morgan Stanley raising its target to $267, and JPMorgan upgrading the stock to Overweight with a $291 price forecast.

International Business Machines Corp. on Thursday unveiled the world's first sub-1-nanometer chip technology, introducing a new three-dimensional nanostack transistor architecture designed to extend semiconductor scaling beyond current manufacturing limits. The 0.7-nanometer chip packs nearly 100 billion transistors onto a fingernail-sized chip, nearly doubling the density of its 2-nanometer chip introduced in 2021. The technology could deliver up to 50% higher performance or 70% greater energy efficiency than its 2-nanometer chips, with potential applications in AI, cloud computing, and next-generation electronics. The company expects the earliest commercial adoption of the technology within the next five years.

Technical Performance

IBM stock is trading lower on Thursday. The stock is trading 2.7% above its 50-day simple moving average of $252.38 and 2.5% above its 100-day SMA of $252.98. However, the stock remains 6.9% below its 20-day SMA of $278.54 and 5.3% below its 200-day SMA of $273.66. The stock’s relative strength index stands at 46.88, indicating neutral momentum. Key resistance is near $260.50, while support is around $212.50.

Earnings And Analyst Outlook

The company’s next major catalyst is its scheduled July 22 earnings report. Analysts expect earnings of $3.01 per share on revenue of $17.86 billion, up from $2.80 per share and $16.98 billion, respectively, a year earlier. The stock carries a consensus Buy rating with an average price forecast of $301.07. Recent analyst actions include JPMorgan upgrading IBM to Overweight with a $291 price forecast, Morgan Stanley raising its Equal-Weight price forecast to $267, and Citigroup maintaining its Buy rating while lifting its price forecast to $375.